L. Shubitz

发表

TNFα Blockade Inhibits Both Initial and Continued Control of Pulmonary Coccidioides

J. Frelinger, J. Galgiani, D. Powell, 2022, Frontiers in Cellular and Infection Microbiology.

A Chronic Murine Disease Model of Coccidioidomycosis Using Coccidioides posadasii, strain 1038.

J. Frelinger, J. Galgiani, M. Orbach, 2020, The Journal of infectious diseases.

Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials

T. Monath, J. Galgiani, M. Orbach, 2022, Journal of fungi.

Localization within a Proline-Rich Antigen (Ag2/PRA) of Protective Antigenicity against Infection with Coccidioides immitis in Mice

J. Galgiani, J. Simons, K. Orsborn, 2002, Infection and Immunity.

T-Lymphocyte Predominance in Lesions of Canine Coccidioidomycosis

J. Galgiani, S. Dial, L. Shubitz, 2011, Veterinary pathology.

Early Events in Coccidioidomycosis

J. Frelinger, J. Galgiani, M. Orbach, 2019, Clinical Microbiology Reviews.

Detecting Pulmonary Coccidioidomycosis (Valley fever) with Deep Convolutional Neural Networks pdf

Pierre Baldi, Jordan Ott, Silke Hecht, 2021, ArXiv.

Comparative Aspects of Coccidioidomycosis in Animals and Humans

L. Shubitz, 2007, Annals of the New York Academy of Sciences.

Detecting pulmonary Coccidioidomycosis with deep convolutional neural networks

Pierre Baldi, Jordan Ott, Silke Hecht, 2021 .

Protection of Mice against Coccidioides immitis Intranasal Infection by Vaccination with Recombinant Antigen 2/PRA

J. Galgiani, J. Simons, K. Orsborn, 2002, Infection and Immunity.

Coccidioidomycosis in dogs and cats: a review.

B. Valentine, S. Tornquist, S. Dial, 2008, Journal of the American Animal Hospital Association.

The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis

E. Garvey, C. M. Yates, R. Schotzinger, 2018, Antimicrobial Agents and Chemotherapy.

Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models

E. Garvey, J. Galgiani, B. Barker, 2015, Antimicrobial Agents and Chemotherapy.

Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

J. Galgiani, C. Thompson, D. Nix, 2014, The Journal of infectious diseases.

Efficacy of Nikkomycin Z for respiratory coccidioidomycosis in naturally infected dogs.

J. Galgiani, D. Nix, Michael E. Roy, 2013, Medical mycology.

Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

J. Galgiani, T. Kirkland, J. Simons, 2006, Vaccine.

Coccidioides Species: A Review of Basic Research: 2022

J. Fierer, John W. Taylor, D. Stevens, 2022, Journal of fungi.

The WOPR family protein Ryp1 is a key regulator of gene expression, development, and virulence in the thermally dimorphic fungal pathogen Coccidioides posadasii

J. Galgiani, M. Orbach, S. Beyhan, 2021, bioRxiv.

A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection

J. Frelinger, J. Galgiani, M. Orbach, 2016, Infection and Immunity.

Protein Expression Profiling of Coccidioides posadasii by Two-Dimensional Differential In-Gel Electrophoresis and Evaluation of a Newly Recognized Peroxisomal Matrix Protein as a Recombinant Vaccine Candidate

J. Galgiani, E. M. Kellner, M. Orbach, 2006, Infection and Immunity.

Clinical features of cats diagnosed with coccidioidomycosis in Arizona, 2004–2018

L. Shubitz, Christine D Butkiewicz, M. Keyes, 2020, Journal of feline medicine and surgery.

Selected Clinical Features of Coccidioidomycosis in Dogs.

J. Sykes, A. Davidson, C. Alcott, 2019, Medical mycology.

Development of an enzyme immunoassay for detection of antibodies against Coccidioides in dogs and other mammalian species

A. Litvintseva, O. Mccotter, T. Chiller, 2017, PloS one.

Coccidioidomycosis: a diagnostic challenge.

S. Dial, L. Shubitz, 2005, Clinical techniques in small animal practice.

Constrictive pericarditis secondary to Coccidioides immitis infection in a dog.

G. Bradley, C. Reggiardo, T. Noon, 2001, Journal of the American Veterinary Medical Association.

Efficacy of Ambruticin Analogs in a Murine Model of Coccidioidomycosis

J. Galgiani, L. Katz, Z. Zhong, 2006, Antimicrobial Agents and Chemotherapy.

Detection and phylogenetic analysis of Coccidioides posadasii in Arizona soil samples

B. Barker, J. Tabor, M. Orbach, 2012 .

Coccidioides posadasii in a Dog With Cervical Dissemination Complicated by Esophageal Fistula

M. Orbach, J. Jaffey, Stephanie D Szabo, 2020, Frontiers in Veterinary Science.

Resistance to Coccidioides immitis in Mice after Immunization with Recombinant Protein or a DNA Vaccine of a Proline-Rich Antigen

J. Galgiani, E. Brummer, D. Stevens, 1999, Infection and Immunity.

Mouse Model of a Human STAT4 Point Mutation That Predisposes to Disseminated Coccidiomycosis

J. Frelinger, S. Holland, T. Doetschman, 2022, ImmunoHorizons.

Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis

J. Frelinger, S. Holland, A. Hsu, 2022, Frontiers in Cellular and Infection Microbiology.

Evaluation of Host Constitutive and Ex Vivo Coccidioidal Antigen-Stimulated Immune Response in Dogs with Naturally Acquired Coccidioidomycosis

J. Jaffey, A. Murthy, A. D. da Cunha, 2023, Journal of fungi.

Mouse models for the study of fungal pneumonia

A. Casadevall, J. Galgiani, E. Mylonakis, 2012, Virulence.

Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

J. Frelinger, J. Galgiani, M. Orbach, 2018, Vaccine.

Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease

J. Frelinger, A. Hsu, J. Galgiani, 2022, Journal of fungi.

Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs

E. Garvey, R. Schotzinger, Michael E. Roy, 2017, Antimicrobial Agents and Chemotherapy.

Serum 25‐hydroxyvitamin D concentrations in dogs with coccidioidomycosis and variables associated with extent of clinically evident disease

J. Jaffey, K. Wycislo, R. Backus, 2023, Journal of veterinary internal medicine.

The utility of Coccidioides antigen and antibody detection in cerebrospinal fluid in the diagnosis of canine central nervous system coccidioidomycosis.

L. Wheat, C. Alcott, L. Shubitz, 2022, American journal of veterinary research.

Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis

J. Frelinger, J. Galgiani, M. Orbach, 2021, Vaccine.

Evaluation of a commercially available, point-of-care Coccidioides antibody lateral flow assay to aid in rapid diagnosis of coccidioidomycosis in dogs.

L. Shubitz, Christine D Butkiewicz, Polina Vishkautsan, 2020, Medical mycology.

Coccidioidomycosis in alpacas in the southwestern United States

L. Shubitz, Christine D Butkiewicz, 2018, Transboundary and emerging diseases.

Vaccine-Induced Cellular Immune Responses Differ from Innate Responses in Susceptible and Resistant Strains of Mice Infected with Coccidioides posadasii

J. Galgiani, S. Dial, L. Shubitz, 2008, Infection and Immunity.

Differentiating lung cancer and infection based on measurements of extracellular pH with acidoCEST MRI

Kyle M. Jones, M. Pagel, C. Howison, 2019, Scientific Reports.

Immunogenetics associated with severe coccidioidomycosis

Andrew J. Oler, E. Karlins, J. Frelinger, 2022, JCI insight.

The Host Response to Coccidioidomycosis

S. Beyhan, C. Hung, L. Shubitz, 2024, Journal of fungi.

Discovery of a Unique Set of Dog-Seroreactive Coccidioides Proteins Using Nucleic Acid Programmable Protein Array

Lusheng Song, M. Orbach, Yunro Chung, 2024, Journal of fungi.